Polycystic ovary syndrome (PCOS), pathophysiology and treatment, a review

Authors

DOI:

https://doi.org/10.33448/rsd-v11i9.32469

Keywords:

Polycystic ovary syndrome; Infertility; Reproduction.

Abstract

Polycystic ovary syndrome is a pathology of multifactorial etiology and one of the main causes of female infertility worldwide. In addition to changes in reproductive physiology, such as irregular menstrual cycles, anovulation, hyperandrogenism and the presence of multiple ovarian cysts, metabolic changes also occur that can affect the quality of life and survival of women with the syndrome. Endocrine impairment linked to polycystic ovary syndrome occurs due to the development of metabolic syndrome, a condition characterized by impaired glucose tolerance, dyslipidemia and hypertension. However, the manifestation of symptoms associated with polycystic ovary syndrome depends on the interaction between genetic and epigenetic factors, lifestyle and eating habits. The interrelationship between these factors results in the phenotypic diversity presented by women with the syndrome. That is, the clinical manifestations and symptomatic severity vary among the carrier women, so that the treatment is individualized for each patient. The therapeutic management of the syndrome is aimed at symptomatic relief and ovulation induction, since there is still no curative treatment. This narrative review aims to highlight the main clinical, endocrine and metabolic aspects of polycystic ovary syndrome, one of the main causes of female infertility.

References

Abraham Gnanadass, S., Divakar Prabhu, Y., & Valsala Gopalakrishnan, A. (2021). Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Archives of Gynecology and Obstetrics, 303(3), 631–643. https://doi.org/10.1007/s00404-020-05951-2

Azevedo, M. M. P., de Marqui, A. B. T., Bacalá, B. T., Balarin, M. A. S., de Resende, E. A. M. R., Lima, M. F. P., de Oliveira Gomes, M. K., & Cintra, M. T. R. (2021). Polymorphisms of the GSTT1 and GSTM1 genes in polycystic ovary syndrome. Revista Da Associacao Medica Brasileira, 66(11), 1560–1565. https://doi.org/10.1590/1806-9282.66.11.1560

Chan, J. L., Kar, S., Vanky, E., Morin-Papunen, L., Piltonen, T., Puurunen, J., Tapanainen, J. S., Maciel, G. A. R., Hayashida, S. A. Y., Soares, J. M., Baracat, E. C., Mellembakken, J. R., & Dokras, A. (2017). Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study. American Journal of Obstetrics and Gynecology, 217(2), 189.e1-189.e8. https://doi.org/10.1016/j.ajog.2017.04.007

Cordeiro, A. M., de Oliveira, G. M., Rentería, J. M., & Guimarães, C. A. (2007). Revisão sistemática: uma revisão narrativa. Revista Do Colégio Brasileiro de Cirurgiões, 34(6), 428–431. https://doi.org/10.1590/S0100-69912007000600012

De Andrade, V. H. L., Da Mata, A. M. O. F., Borges, R. S., Costa-Silva, D. R., Martins, L. M., Ferreira, P. M. P., Cunha-Nunes, L. C., & Da Silva, B. B. (2016). Current aspects of polycystic ovary syndrome: A literature review. Revista Da Associacao Medica Brasileira, 62(9), 867–871. https://doi.org/10.1590/1806-9282.62.09.867

Fernandes, S. S., de Marqui, A. B. T., Teles, D. R. F., Resende, E. A. M. R., Lima, M. F. P., Gomes, M. K. O., & Cintra, M. T. R. (2020). VEGF gene rs35569394 polymorphism in patients with Polycystic Ovary Syndrome. Revista Da Associacao Medica Brasileira, 66(10), 1396–1401. https://doi.org/10.1590/1806-9282.66.10.1396

Gao, X. ying, Liu, Y., Lv, Y., Huang, T., Lu, G., Liu, H. bin, & Zhao, S. gang. (2020). Role of Androgen Receptor for Reconsidering the “True” Polycystic Ovarian Morphology in PCOS. Scientific Reports, 10(1), 1–7. https://doi.org/10.1038/s41598-020-65890-5

Guliyev, D. A., Cabuk, K. S., Kirgiz, A., Usta, A. T., Kovalak, E. E., Guliyev, V., & Taskapili, M. (2016). Tear osm olarity and tear function assessment in patients with polycystic ovary syndrome. Revista Brasileira de Oftalmologia, 75(5), 380–384. https://doi.org/10.5935/0034-7280.20160076

Hueb, C. K., Júnior, J. A. D., Abrão, M. S., & Filho, E. K. (2015). Drilling: Medical indications and surgical technique. Revista Da Associacao Medica Brasileira, 61(6), 530–535. https://doi.org/10.1590/1806-9282.61.06.530

Iwata, M. C., Porquere, L., Espósito Sorpreso, I. C., Baracat, E. C., & Júnior, J. M. S. (2015). Association of oral contraceptive and metformin did not improve insulin resistance in women with polycystic ovary syndrome. Revista Da Associacao Medica Brasileira, 61(3), 215–219. https://doi.org/10.1590/1806-9282.61.03.215

Koch, T., Doherty, D. A., Dickinson, J. E., Juul, A., Hart, R., Bräuner, E. V., & Hickey, M. (2021). In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study. Psychoneuroendocrinology, 125(August 2020). https://doi.org/10.1016/j.psyneuen.2020.105104

Krentowska, A., Łebkowska, A., Jacewicz-Święcka, M., Hryniewicka, J., Leśniewska, M., Adamska, A., & Kowalska, I. (2021). Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome. Endocrine, 72(2), 400–410. https://doi.org/10.1007/s12020-020-02596-8

Lana, M. P., Demayo, S., Giannone, L., Nolting, M., D’isa, E., Servetti, V., Rolo, G., Gutierrez, G., & Jarlip, M. (2020). Metabolic compromise in women with PCOS: Earlier than expected. Revista Da Associacao Medica Brasileira, 66(9), 1225–1228. https://doi.org/10.1590/1806-9282.66.9.1225

Maffazioli, G. D. N., Lopes, C. P., Heinrich-Oliveira, V., Lobo, R. A., Hayashida, S. A. Y., Soares, J. M., Maciel, G. A. R., & Baracat, E. C. (2020). Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil. International Journal of Gynecology and Obstetrics, 151(3), 383–391. https://doi.org/10.1002/ijgo.13374

Prieto-Sánchez, M. T., Hernández-Peñalver, A. I., Sánchez-Ferrer, M. L., Mendiola, J., & Torres-Cantero, A. M. (2020). Anogenital distance and anti-Müllerian hormone combined improves the diagnosis of polycystic ovary syndrome. Human Fertility, 0(0), 1–9. https://doi.org/10.1080/14647273.2020.1795574

Rao, P., & Bhide, P. (2020). Controversies in the diagnosis of polycystic ovary syndrome. Therapeutic Advances in Reproductive Health, 14, 263349412091303. https://doi.org/10.1177/2633494120913032

Spritzer, P. M., Marchesan, L. B., Santos, B. R., Cureau, F. V., Oppermann, K., Reis, R. M. Dos, Ferriani, R. A., Weiss, R., Meirelles, R., Candido, A. L., & Reis, F. M. (2019). Prevalence and characteristics of polycystic ovary syndrome in Brazilian women: Protocol for a nation-wide case-control study. BMJ Open, 9(10), 1–8. https://doi.org/10.1136/bmjopen-2019-029191

Stener-Victorin, E., Padmanabhan, V., Walters, K. A., Campbell, R. E., Benrick, A., Giacobini, P., Dumesic, D. A., & Abbott, D. H. (2020). Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome. Endocrine Reviews, 41(4), 538–576. https://doi.org/10.1210/endrev/bnaa010

Tavares, A., & Rêgo Barros, R. C. (2019). The Prevalence of Metabolic Syndrome in the Different Phenotypes of Polycystic Ovarian Syndrome. Revista Brasileira de Ginecologia e Obstetricia, 41(1), 37–43. https://doi.org/10.1055/s-0038-1676568

Ventrículo, A., Pulmonar, D., Abacioglu, O. O., Gulumsek, E., Sumbul, H. E., & Kaplan, M. (n.d.). Artigo Original Aumento da Rigidez Arterial Pulmonar e Comprometimento do. 806–812.

Published

20/07/2022

How to Cite

ALVES , M. L. S. .; DONNE , R. D. D. .; ROMANO, R. M. .; ROMANO, M. A. Polycystic ovary syndrome (PCOS), pathophysiology and treatment, a review. Research, Society and Development, [S. l.], v. 11, n. 9, p. e25111932469, 2022. DOI: 10.33448/rsd-v11i9.32469. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/32469. Acesso em: 25 apr. 2024.

Issue

Section

Review Article